How this instrument works
HAS-BLED sums nine risk factors, each worth exactly one point: uncontrolled Hypertension, Abnormal renal function, Abnormal liver function, prior Stroke, a Bleeding history or predisposition, Labile INR, Elderly (over 65), Drug use — antiplatelets or NSAIDs — and Alcohol use of 8 or more drinks a week. The total runs 0 to 9. Note that the acronym's seven letters don't line up one-to-one with the nine points: the 'A' covers two separate, independently scored items (renal function and liver function), and the 'D' likewise covers two (drugs and alcohol) — a detail worth knowing before assuming the name maps cleanly onto the arithmetic.
Pisters, Lane, Nieuwlaat, de Vos, Crijns, and Lip built and validated the score in a 2010 Chest paper using data from the Euro Heart Survey on atrial fibrillation, aiming to estimate one-year risk of major bleeding in patients being considered for anticoagulant therapy. A total of 3 or more is the published cutoff for 'high bleeding risk' — a threshold meant to prompt a closer look at the patient's modifiable risk factors, not to answer the anticoagulation question by itself.
That distinction matters because a high HAS-BLED total often shows up in the same patient as a high stroke-risk score, like CHA2DS2-VASc, also covered on this site — hypertension, older age, and prior stroke drive both scores upward together. The point of HAS-BLED was never 'don't anticoagulate this patient'; a high score commonly coexists with a strong case for anticoagulation on stroke-risk grounds. Instead, a high total is a prompt to review what can be changed — tightening blood pressure control, reassessing concurrent NSAID use, stabilizing a labile INR — and to monitor more closely, so the anticoagulation decision proceeds with the bleeding risk actively managed rather than ignored.
- Toggle Hypertension (uncontrolled, systolic over 160).
- Toggle Abnormal renal function and Abnormal liver function separately — both fall under HAS-BLED's 'A', but each scores its own point.
- Toggle Prior stroke and Bleeding history or predisposition.
- Toggle Labile INR (time in therapeutic range under 60%) and Age over 65.
- Toggle Drug use (antiplatelet or NSAID) and Alcohol use (8+ drinks/week) — both fall under 'D', each scoring its own point.
- Read the total, 0 to 9; a score of 3 or more is the published high-bleeding-risk threshold.
Worked example — 4 points against the 0-to-9 range
A patient has uncontrolled hypertension, a prior stroke, a labile INR, and is over 65, with normal renal and liver function, no bleeding history, and no qualifying drug or alcohol use: 1 + 1 + 1 + 1 = 4, above the published cutoff of 3, flagging high bleeding risk and a case for closer monitoring alongside whatever the anticoagulation decision turns out to be.
The scale's two extremes bracket that 4: a patient with none of the nine factors present scores 0 + 0 + 0 + 0 + 0 + 0 + 0 + 0 + 0 = 0, the floor. A patient with every one of the nine factors present — including both abnormal renal and abnormal liver function, and both qualifying drug and alcohol use — scores the maximum, 9, the ceiling the instrument allows.
Questions
What does a HAS-BLED score of 4 mean?
It sits above the published cutoff of 3, which the 2010 Chest derivation study associated with higher one-year major bleeding risk on anticoagulation. In practice that reading prompts a clinician to look harder at which of the four contributing factors can be modified — blood pressure control and INR stability, for instance — rather than serving as an automatic reason to withhold treatment.
Why does HAS-BLED have 9 points but only 7 letters in its name?
Because two of the seven letters each stand for two separately scored criteria. The 'A' represents both Abnormal renal function and Abnormal liver function, worth a point each, and the 'D' represents both Drug use (antiplatelets or NSAIDs) and Alcohol use, also worth a point each. Add those four to the five single-letter, single-criterion factors — Hypertension, Stroke, Bleeding history, Labile INR, Elderly — and the total climbs from seven letters to nine scoring items.
Does a high HAS-BLED score mean a patient shouldn't be anticoagulated?
No — that reading misses the point of the score. HAS-BLED estimates bleeding risk on treatment, and a high total frequently occurs in patients who also carry a high stroke-risk score, like CHA2DS2-VASc, which argues for anticoagulation in the first place. Rather than a veto, a high HAS-BLED total is meant to flag closer monitoring and to prompt correction of modifiable risk factors — blood pressure, INR stability, concurrent NSAID use — alongside the anticoagulation decision, not instead of it.
How does HAS-BLED relate to CHA2DS2-VASc?
They answer different questions about the same patient: CHA2DS2-VASc, also available on this site, estimates stroke risk from atrial fibrillation, while HAS-BLED estimates bleeding risk from the anticoagulation used to prevent that stroke. Clinicians commonly calculate both together, since several factors — hypertension and age over 65 among them — raise both scores at once, and the anticoagulation decision weighs the two risks against each other rather than looking at either score alone.
What counts as abnormal renal or liver function in HAS-BLED?
Abnormal renal function is defined as chronic dialysis, a prior kidney transplant, or a serum creatinine of 200 µmol/L or higher. Abnormal liver function is defined as chronic liver disease such as cirrhosis, or biochemical evidence of significant hepatic derangement — bilirubin more than twice the upper limit of normal alongside markedly elevated liver enzymes. Each is checked and scored independently, even though both fall under the single letter 'A.'
Are all nine HAS-BLED risk factors equally fixed, or can some be changed?
Some genuinely can't be altered — age and a prior stroke are fixed facts of history. Others are explicitly modifiable, which is part of why the score is useful beyond a single number: uncontrolled hypertension can be treated, a labile INR can be stabilized with closer monitoring or a different anticoagulant, and concurrent antiplatelet or NSAID use can often be reviewed and reduced. A clinician reading a high total is meant to look for exactly these levers, not just the total itself.
References
- Pisters, Lane, Nieuwlaat, de Vos, Crijns & Lip 2010, Chest — HAS-BLED derivation (PubMed)
- American Heart Association — Atrial Fibrillation
Read this first: This instrument computes a screening figure from population formulas — it is not a diagnosis, and it cannot see the whole picture a clinician can. Use it to inform a conversation, not to replace one.